Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys.
Identifieur interne : 003E57 ( Ncbi/Merge ); précédent : 003E56; suivant : 003E58Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys.
Auteurs : M M Claassens [Afrique du Sud] ; C. Van Schalkwyk [Afrique du Sud] ; S. Floyd [Royaume-Uni] ; H. Ayles [Royaume-Uni] ; N. Beyers [Afrique du Sud]Source :
- PloS one [ 1932-6203 ] ; 2017.
Descripteurs français
- KwdFr :
- Dyspnée (microbiologie), Dyspnée (sang), Dépistage systématique, Expectoration (microbiologie), Femelle, Fièvre (microbiologie), Fièvre (sang), Fièvre (épidémiologie), Humains, Infections à VIH (sang), Infections à VIH (épidémiologie), Maladies transmissibles (microbiologie), Maladies transmissibles (sang), Maladies transmissibles (épidémiologie), Mycobacterium tuberculosis (pathogénicité), Mâle, Population d'origine africaine, Sueur (microbiologie), Toux (microbiologie), Toux (sang), Toux (épidémiologie), Tuberculose (microbiologie), Tuberculose (sang), Tuberculose (épidémiologie), Zambie.
- MESH :
- microbiologie : Dyspnée, Expectoration, Fièvre, Maladies transmissibles, Sueur, Toux, Tuberculose.
- pathogénicité : Mycobacterium tuberculosis.
- sang : Dyspnée, Fièvre, Infections à VIH, Maladies transmissibles, Toux, Tuberculose.
- épidémiologie : Fièvre, Infections à VIH, Maladies transmissibles, Toux, Tuberculose.
- Dépistage systématique, Femelle, Humains, Mâle, Population d'origine africaine, Zambie.
English descriptors
- KwdEn :
- African Continental Ancestry Group, Communicable Diseases (blood), Communicable Diseases (epidemiology), Communicable Diseases (microbiology), Cough (blood), Cough (epidemiology), Cough (microbiology), Dyspnea (blood), Dyspnea (microbiology), Female, Fever (blood), Fever (epidemiology), Fever (microbiology), HIV Infections (blood), HIV Infections (epidemiology), Humans, Male, Mass Screening, Mycobacterium tuberculosis (pathogenicity), Sputum (microbiology), Sweat (microbiology), Tuberculosis (blood), Tuberculosis (epidemiology), Tuberculosis (microbiology), Zambia.
- MESH :
- blood : Communicable Diseases, Cough, Dyspnea, Fever, HIV Infections, Tuberculosis.
- epidemiology : Communicable Diseases, Cough, Fever, HIV Infections, Tuberculosis.
- microbiology : Communicable Diseases, Cough, Dyspnea, Fever, Sputum, Sweat, Tuberculosis.
- pathogenicity : Mycobacterium tuberculosis.
- African Continental Ancestry Group, Female, Humans, Male, Mass Screening, Zambia.
Abstract
High tuberculosis (TB) burden countries should consider systematic screening among adults in the general population. We identified symptom screening rules to be used in addition to cough ≥2 weeks, in a context where X-ray screening is not feasible, aiming to increase the sensitivity of screening while achieving a specificity of ≥85%.
DOI: 10.1371/journal.pone.0172881
PubMed: 28257424
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000642
- to stream PubMed, to step Curation: 000642
- to stream PubMed, to step Checkpoint: 000642
Links to Exploration step
pubmed:28257424Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys.</title><author><name sortKey="Claassens, M M" sort="Claassens, M M" uniqKey="Claassens M" first="M M" last="Claassens">M M Claassens</name><affiliation wicri:level="1"><nlm:affiliation>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town</wicri:regionArea><wicri:noRegion>Cape Town</wicri:noRegion></affiliation></author><author><name sortKey="Van Schalkwyk, C" sort="Van Schalkwyk, C" uniqKey="Van Schalkwyk C" first="C" last="Van Schalkwyk">C. Van Schalkwyk</name><affiliation wicri:level="1"><nlm:affiliation>The South African Department of Science and Technology/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>The South African Department of Science and Technology/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch</wicri:regionArea><wicri:noRegion>Stellenbosch</wicri:noRegion></affiliation></author><author><name sortKey="Floyd, S" sort="Floyd, S" uniqKey="Floyd S" first="S" last="Floyd">S. Floyd</name><affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Clinical Research, London School of Hygiene and Tropical Medicine, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Ayles, H" sort="Ayles, H" uniqKey="Ayles H" first="H" last="Ayles">H. Ayles</name><affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Clinical Research, London School of Hygiene and Tropical Medicine, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Beyers, N" sort="Beyers, N" uniqKey="Beyers N" first="N" last="Beyers">N. Beyers</name><affiliation wicri:level="1"><nlm:affiliation>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town</wicri:regionArea><wicri:noRegion>Cape Town</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28257424</idno><idno type="pmid">28257424</idno><idno type="doi">10.1371/journal.pone.0172881</idno><idno type="wicri:Area/PubMed/Corpus">000642</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000642</idno><idno type="wicri:Area/PubMed/Curation">000642</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000642</idno><idno type="wicri:Area/PubMed/Checkpoint">000642</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000642</idno><idno type="wicri:Area/Ncbi/Merge">003E57</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys.</title><author><name sortKey="Claassens, M M" sort="Claassens, M M" uniqKey="Claassens M" first="M M" last="Claassens">M M Claassens</name><affiliation wicri:level="1"><nlm:affiliation>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town</wicri:regionArea><wicri:noRegion>Cape Town</wicri:noRegion></affiliation></author><author><name sortKey="Van Schalkwyk, C" sort="Van Schalkwyk, C" uniqKey="Van Schalkwyk C" first="C" last="Van Schalkwyk">C. Van Schalkwyk</name><affiliation wicri:level="1"><nlm:affiliation>The South African Department of Science and Technology/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>The South African Department of Science and Technology/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch</wicri:regionArea><wicri:noRegion>Stellenbosch</wicri:noRegion></affiliation></author><author><name sortKey="Floyd, S" sort="Floyd, S" uniqKey="Floyd S" first="S" last="Floyd">S. Floyd</name><affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Clinical Research, London School of Hygiene and Tropical Medicine, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Ayles, H" sort="Ayles, H" uniqKey="Ayles H" first="H" last="Ayles">H. Ayles</name><affiliation wicri:level="3"><nlm:affiliation>Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Clinical Research, London School of Hygiene and Tropical Medicine, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Beyers, N" sort="Beyers, N" uniqKey="Beyers N" first="N" last="Beyers">N. Beyers</name><affiliation wicri:level="1"><nlm:affiliation>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.</nlm:affiliation><country xml:lang="fr">Afrique du Sud</country><wicri:regionArea>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town</wicri:regionArea><wicri:noRegion>Cape Town</wicri:noRegion></affiliation></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>African Continental Ancestry Group</term><term>Communicable Diseases (blood)</term><term>Communicable Diseases (epidemiology)</term><term>Communicable Diseases (microbiology)</term><term>Cough (blood)</term><term>Cough (epidemiology)</term><term>Cough (microbiology)</term><term>Dyspnea (blood)</term><term>Dyspnea (microbiology)</term><term>Female</term><term>Fever (blood)</term><term>Fever (epidemiology)</term><term>Fever (microbiology)</term><term>HIV Infections (blood)</term><term>HIV Infections (epidemiology)</term><term>Humans</term><term>Male</term><term>Mass Screening</term><term>Mycobacterium tuberculosis (pathogenicity)</term><term>Sputum (microbiology)</term><term>Sweat (microbiology)</term><term>Tuberculosis (blood)</term><term>Tuberculosis (epidemiology)</term><term>Tuberculosis (microbiology)</term><term>Zambia</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Dyspnée (microbiologie)</term><term>Dyspnée (sang)</term><term>Dépistage systématique</term><term>Expectoration (microbiologie)</term><term>Femelle</term><term>Fièvre (microbiologie)</term><term>Fièvre (sang)</term><term>Fièvre (épidémiologie)</term><term>Humains</term><term>Infections à VIH (sang)</term><term>Infections à VIH (épidémiologie)</term><term>Maladies transmissibles (microbiologie)</term><term>Maladies transmissibles (sang)</term><term>Maladies transmissibles (épidémiologie)</term><term>Mycobacterium tuberculosis (pathogénicité)</term><term>Mâle</term><term>Population d'origine africaine</term><term>Sueur (microbiologie)</term><term>Toux (microbiologie)</term><term>Toux (sang)</term><term>Toux (épidémiologie)</term><term>Tuberculose (microbiologie)</term><term>Tuberculose (sang)</term><term>Tuberculose (épidémiologie)</term><term>Zambie</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Communicable Diseases</term><term>Cough</term><term>Dyspnea</term><term>Fever</term><term>HIV Infections</term><term>Tuberculosis</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Communicable Diseases</term><term>Cough</term><term>Fever</term><term>HIV Infections</term><term>Tuberculosis</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Dyspnée</term><term>Expectoration</term><term>Fièvre</term><term>Maladies transmissibles</term><term>Sueur</term><term>Toux</term><term>Tuberculose</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Communicable Diseases</term><term>Cough</term><term>Dyspnea</term><term>Fever</term><term>Sputum</term><term>Sweat</term><term>Tuberculosis</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Mycobacterium tuberculosis</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Mycobacterium tuberculosis</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Dyspnée</term><term>Fièvre</term><term>Infections à VIH</term><term>Maladies transmissibles</term><term>Toux</term><term>Tuberculose</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Fièvre</term><term>Infections à VIH</term><term>Maladies transmissibles</term><term>Toux</term><term>Tuberculose</term></keywords><keywords scheme="MESH" xml:lang="en"><term>African Continental Ancestry Group</term><term>Female</term><term>Humans</term><term>Male</term><term>Mass Screening</term><term>Zambia</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Dépistage systématique</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Population d'origine africaine</term><term>Zambie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">High tuberculosis (TB) burden countries should consider systematic screening among adults in the general population. We identified symptom screening rules to be used in addition to cough ≥2 weeks, in a context where X-ray screening is not feasible, aiming to increase the sensitivity of screening while achieving a specificity of ≥85%.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28257424</PMID><DateCreated><Year>2017</Year><Month>03</Month><Day>03</Day></DateCreated><DateCompleted><Year>2017</Year><Month>08</Month><Day>22</Day></DateCompleted><DateRevised><Year>2017</Year><Month>08</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys.</ArticleTitle><Pagination><MedlinePgn>e0172881</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0172881</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">High tuberculosis (TB) burden countries should consider systematic screening among adults in the general population. We identified symptom screening rules to be used in addition to cough ≥2 weeks, in a context where X-ray screening is not feasible, aiming to increase the sensitivity of screening while achieving a specificity of ≥85%.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used 2010 Zambia South Africa Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) survey data: a South African (SA) training dataset, a SA testing dataset for internal validation and a Zambian dataset for external validation. Regression analyses investigated relationships between symptoms or combinations of symptoms and active disease. Sensitivity and specificity were calculated for candidate rules.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among all participants, the sensitivity of using only cough ≥2 weeks as a screening rule was less than 25% in both SA and Zambia. The addition of any three of six TB symptoms (cough <2 weeks, night sweats, weight loss, fever, chest pain, shortness of breath), or 2 or more of cough <2 weeks, night sweats, and weight loss, increased the sensitivity to ~38%, while reducing specificity from ~95% to ~85% in SA and ~97% to ~92% in Zambia. Among HIV-negative adults, findings were similar in SA, whereas in Zambia the increase in sensitivity was relatively small (15% to 22%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">High TB burden countries should investigate cost-effective strategies for systematic screening: one such strategy could be to use our rule in addition to cough ≥2 weeks.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Claassens</LastName><ForeName>M M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Schalkwyk</LastName><ForeName>C</ForeName><Initials>C</Initials><Identifier Source="ORCID">http://orcid.org/0000-0001-5154-1390</Identifier><AffiliationInfo><Affiliation>The South African Department of Science and Technology/National Research Foundation Centre of Excellence in Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Floyd</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayles</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zambia AIDS Related Tuberculosis Project, University of Zambia Ridgeway Campus, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beyers</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Desmond Tutu TB Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2013 Oct 5;382(9899):1183-94</RefSource><PMID Version="1">23915882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Emerg Infect Dis. 2007 Aug;13(8):1189-94</RefSource><PMID Version="1">17953090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2011 Apr 15;183(8):1103-11</RefSource><PMID Version="1">21148723</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009;4(5):e5602</RefSource><PMID Version="1">19440346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Tuberc Lung Dis. 2013 Apr;17(4):432-46</RefSource><PMID Version="1">23485377</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2014 Jan 15;9(1):e84511</RefSource><PMID Version="1">24454728</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(7):e38691</RefSource><PMID Version="1">22792158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2002;80(3):217-27</RefSource><PMID Version="1">11984608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013;8(4):e58689</RefSource><PMID Version="1">23560039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Tuberc Lung Dis. 2013 Mar;17(3):289-98</RefSource><PMID Version="1">23407219</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2010 Jan 15;181(2):195-6; author reply 196-7</RefSource><PMID Version="1">20053971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Respir Crit Care Med. 2009 Dec 15;180(12 ):1271-8</RefSource><PMID Version="1">19745207</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2010 Jan;88(1):13-21</RefSource><PMID Version="1">20428349</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2011 Jan 18;8(1):e1000391</RefSource><PMID Version="1">21267059</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2010 Oct 9;376(9748):1244-53</RefSource><PMID Version="1">20923715</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D044383" MajorTopicYN="N">African Continental Ancestry Group</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="N">Communicable Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="Y">Mass Screening</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009169" MajorTopicYN="N">Mycobacterium tuberculosis</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013183" MajorTopicYN="N">Sputum</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013542" MajorTopicYN="N">Sweat</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014376" MajorTopicYN="N">Tuberculosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015024" MajorTopicYN="N">Zambia</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28257424</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0172881</ArticleId><ArticleId IdType="pii">PONE-D-16-41485</ArticleId><ArticleId IdType="pmc">PMC5336223</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Afrique du Sud</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><country name="Afrique du Sud"><noRegion><name sortKey="Claassens, M M" sort="Claassens, M M" uniqKey="Claassens M" first="M M" last="Claassens">M M Claassens</name></noRegion><name sortKey="Beyers, N" sort="Beyers, N" uniqKey="Beyers N" first="N" last="Beyers">N. Beyers</name><name sortKey="Van Schalkwyk, C" sort="Van Schalkwyk, C" uniqKey="Van Schalkwyk C" first="C" last="Van Schalkwyk">C. Van Schalkwyk</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Floyd, S" sort="Floyd, S" uniqKey="Floyd S" first="S" last="Floyd">S. Floyd</name></region><name sortKey="Ayles, H" sort="Ayles, H" uniqKey="Ayles H" first="H" last="Ayles">H. Ayles</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003E57 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003E57 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:28257424
|texte= Symptom screening rules to identify active pulmonary tuberculosis: Findings from the Zambian South African Tuberculosis and HIV/AIDS Reduction (ZAMSTAR) trial prevalence surveys.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:28257424" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |